Section Arrow
Quote
MDWD.NASDAQ
- MediWound Ltd
Quotes are at least 15-min delayed:2025/06/03 22:54 EDT
Last
 21.59
-0.65 (-2.92%)
Day High 
22.48 
Prev. Close
22.24 
1-M High
22.505 
Volume 
89.68K 
Bid
20.01
Ask
22.48
Day Low
21.5 
Open
22.27 
1-M Low
17.1031 
Market Cap 
240.36M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 20.99 
20-SMA 19.84 
50-SMA 17.94 
52-W High 24 
52-W Low 12.78 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.03/-2.32
Enterprise Value
246.88M
Balance Sheet
Book Value Per Share
2.89
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
20.22M
Operating Revenue Per Share
2.41
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NCNANuCana plc0.0598+0.0218+57.37%-- 
RENBRenovaro0.288-0.0019-0.66%-- 
BMEABiomea Fusion2.49+0.94+60.65%-- 
TRAWTraws Pharma Inc1.87+0.45+31.69%-- 
REVBRevelation Biosciences Inc0.9007+0.0777+9.44%-- 
Quotes are at least 15-min delayed：2025/06/03 22:54 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.